This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Starting Depo Provera post-partum

Authoring team

Depo-Provera can be started within 5 days of childbirth or abortion. However if Depo-Provera is started so soon after childbirth then this may cause heavy bleeding and so waiting until 6 weeks post partum is thought to be better (1,2)

Note that current NICE guidance suggests that (3):

  • provided that it is reasonably certain that the woman is not pregnant, the use of injectable contraceptives may be started:
    • up to and including the fifth day of the menstrual cycle without the need for additional contraceptive protection
    • at any other time in the menstrual cycle, but additional barrier contraception should be used for the first 7 days after the injection
    • immediately after first- or second-trimester abortion, or
    • at any time thereafter
    • at any time post-partum

Women who are breast feeding should wait until 6 weeks post partum before starting Depo Provera because medroxyprogesterone acetate and its metabolites are excreted in breast milk. At 6 weeks of age the infant's enzyme system should be more mature (1,2).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.